Selected research
Industry Research
Retrovirus Testing Industry Research Report 2026
Market perspective
The global Retrovirus Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Retrovirus Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Retrovirus Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Retrovirus Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Retrovirus Testing include ZJ Bio-Tech Co., Ltd., Xilong Scientific, Wondfo Biotech, Tellgen Corporation, Bioperfectus Technologies, Sansure Biotech, EasyDiagnosis, Roche and Lepu Medical, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Retrovirus Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Retrovirus Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Retrovirus Testing Market by Company
ZJ Bio-Tech Co., Ltd.
Xilong Scientific
Wondfo Biotech
Tellgen Corporation
Bioperfectus Technologies
Sansure Biotech
EasyDiagnosis
Roche
Lepu Medical
Kehua Bio-Engineering
Hybribio Biotech
BGI Genomics
Dian Diagnostics
Amoy Diagnostics
DiaSorin
bioMérieux
BD
Abbott Diagnostics
Retrovirus Testing Segment by Type
Blood
Serum
Cells
Body Fluids
Retrovirus Testing Segment by Application
Hospitals
Clinics
Others
Retrovirus Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retrovirus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Retrovirus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retrovirus Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Retrovirus Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood
- Serum
- Cells
- Body Fluids
Applications
- Hospitals
- Clinics
- Others
Companies covered
- ZJ Bio-Tech Co., Ltd.
- Xilong Scientific
- Wondfo Biotech
- Tellgen Corporation
- Bioperfectus Technologies
- Sansure Biotech
- EasyDiagnosis
- Roche
- Lepu Medical
- Kehua Bio-Engineering
- Hybribio Biotech
- BGI Genomics
- Dian Diagnostics
- Amoy Diagnostics
- DiaSorin
- bioMérieux
- BD
- Abbott Diagnostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Retrovirus Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood
- 2.2.3 Serum
- 2.2.4 Cells
- 2.2.5 Body Fluids
- 2.3 Retrovirus Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Clinics
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Retrovirus Testing Breakdown Data by Type
- 3.1 Global Retrovirus Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Retrovirus Testing Forecasted Market Size by Type (2027-2032)
4 Retrovirus Testing Breakdown Data by Application
- 4.1 Global Retrovirus Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Retrovirus Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Retrovirus Testing Market Perspective (2021-2032)
- 5.2 Global Retrovirus Testing Growth Trends by Region
- 5.2.1 Global Retrovirus Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Retrovirus Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Retrovirus Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Retrovirus Testing Market Dynamics
- 5.3.1 Retrovirus Testing Industry Trends
- 5.3.2 Retrovirus Testing Market Drivers
- 5.3.3 Retrovirus Testing Market Challenges
- 5.3.4 Retrovirus Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Retrovirus Testing Players by Revenue
- 6.1.1 Global Top Retrovirus Testing Players by Revenue (2021-2026)
- 6.1.2 Global Retrovirus Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Retrovirus Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Retrovirus Testing Head Office and Area Served
- 6.4 Global Retrovirus Testing Players, Product Type & Application
- 6.5 Global Retrovirus Testing Manufacturers Established Date
- 6.6 Global Retrovirus Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Retrovirus Testing Market Size (2021-2032)
- 7.2 North America Retrovirus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Retrovirus Testing Market Size by Country (2021-2026)
- 7.4 North America Retrovirus Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Retrovirus Testing Market Size (2021-2032)
- 8.2 Europe Retrovirus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Retrovirus Testing Market Size by Country (2021-2026)
- 8.4 Europe Retrovirus Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Retrovirus Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Retrovirus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Retrovirus Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Retrovirus Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Retrovirus Testing Market Size (2021-2032)
- 10.2 South America Retrovirus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Retrovirus Testing Market Size by Country (2021-2026)
- 10.4 South America Retrovirus Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Retrovirus Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Retrovirus Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Retrovirus Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Retrovirus Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ZJ Bio-Tech Co., Ltd.
- 12.1.1 ZJ Bio-Tech Co., Ltd. Company Information
- 12.1.2 ZJ Bio-Tech Co., Ltd. Business Overview
- 12.1.3 ZJ Bio-Tech Co., Ltd. Revenue in Retrovirus Testing Business (2021-2026)
- 12.1.4 ZJ Bio-Tech Co., Ltd. Retrovirus Testing Product Portfolio
- 12.1.5 ZJ Bio-Tech Co., Ltd. Recent Developments
- 12.2 Xilong Scientific
- 12.2.1 Xilong Scientific Company Information
- 12.2.2 Xilong Scientific Business Overview
- 12.2.3 Xilong Scientific Revenue in Retrovirus Testing Business (2021-2026)
- 12.2.4 Xilong Scientific Retrovirus Testing Product Portfolio
- 12.2.5 Xilong Scientific Recent Developments
- 12.3 Wondfo Biotech
- 12.3.1 Wondfo Biotech Company Information
- 12.3.2 Wondfo Biotech Business Overview
- 12.3.3 Wondfo Biotech Revenue in Retrovirus Testing Business (2021-2026)
- 12.3.4 Wondfo Biotech Retrovirus Testing Product Portfolio
- 12.3.5 Wondfo Biotech Recent Developments
- 12.4 Tellgen Corporation
- 12.4.1 Tellgen Corporation Company Information
- 12.4.2 Tellgen Corporation Business Overview
- 12.4.3 Tellgen Corporation Revenue in Retrovirus Testing Business (2021-2026)
- 12.4.4 Tellgen Corporation Retrovirus Testing Product Portfolio
- 12.4.5 Tellgen Corporation Recent Developments
- 12.5 Bioperfectus Technologies
- 12.5.1 Bioperfectus Technologies Company Information
- 12.5.2 Bioperfectus Technologies Business Overview
- 12.5.3 Bioperfectus Technologies Revenue in Retrovirus Testing Business (2021-2026)
- 12.5.4 Bioperfectus Technologies Retrovirus Testing Product Portfolio
- 12.5.5 Bioperfectus Technologies Recent Developments
- 12.6 Sansure Biotech
- 12.6.1 Sansure Biotech Company Information
- 12.6.2 Sansure Biotech Business Overview
- 12.6.3 Sansure Biotech Revenue in Retrovirus Testing Business (2021-2026)
- 12.6.4 Sansure Biotech Retrovirus Testing Product Portfolio
- 12.6.5 Sansure Biotech Recent Developments
- 12.7 EasyDiagnosis
- 12.7.1 EasyDiagnosis Company Information
- 12.7.2 EasyDiagnosis Business Overview
- 12.7.3 EasyDiagnosis Revenue in Retrovirus Testing Business (2021-2026)
- 12.7.4 EasyDiagnosis Retrovirus Testing Product Portfolio
- 12.7.5 EasyDiagnosis Recent Developments
- 12.8 Roche
- 12.8.1 Roche Company Information
- 12.8.2 Roche Business Overview
- 12.8.3 Roche Revenue in Retrovirus Testing Business (2021-2026)
- 12.8.4 Roche Retrovirus Testing Product Portfolio
- 12.8.5 Roche Recent Developments
- 12.9 Lepu Medical
- 12.9.1 Lepu Medical Company Information
- 12.9.2 Lepu Medical Business Overview
- 12.9.3 Lepu Medical Revenue in Retrovirus Testing Business (2021-2026)
- 12.9.4 Lepu Medical Retrovirus Testing Product Portfolio
- 12.9.5 Lepu Medical Recent Developments
- 12.10 Kehua Bio-Engineering
- 12.10.1 Kehua Bio-Engineering Company Information
- 12.10.2 Kehua Bio-Engineering Business Overview
- 12.10.3 Kehua Bio-Engineering Revenue in Retrovirus Testing Business (2021-2026)
- 12.10.4 Kehua Bio-Engineering Retrovirus Testing Product Portfolio
- 12.10.5 Kehua Bio-Engineering Recent Developments
- 12.11 Hybribio Biotech
- 12.11.1 Hybribio Biotech Company Information
- 12.11.2 Hybribio Biotech Business Overview
- 12.11.3 Hybribio Biotech Revenue in Retrovirus Testing Business (2021-2026)
- 12.11.4 Hybribio Biotech Retrovirus Testing Product Portfolio
- 12.11.5 Hybribio Biotech Recent Developments
- 12.12 BGI Genomics
- 12.12.1 BGI Genomics Company Information
- 12.12.2 BGI Genomics Business Overview
- 12.12.3 BGI Genomics Revenue in Retrovirus Testing Business (2021-2026)
- 12.12.4 BGI Genomics Retrovirus Testing Product Portfolio
- 12.12.5 BGI Genomics Recent Developments
- 12.13 Dian Diagnostics
- 12.13.1 Dian Diagnostics Company Information
- 12.13.2 Dian Diagnostics Business Overview
- 12.13.3 Dian Diagnostics Revenue in Retrovirus Testing Business (2021-2026)
- 12.13.4 Dian Diagnostics Retrovirus Testing Product Portfolio
- 12.13.5 Dian Diagnostics Recent Developments
- 12.14 Amoy Diagnostics
- 12.14.1 Amoy Diagnostics Company Information
- 12.14.2 Amoy Diagnostics Business Overview
- 12.14.3 Amoy Diagnostics Revenue in Retrovirus Testing Business (2021-2026)
- 12.14.4 Amoy Diagnostics Retrovirus Testing Product Portfolio
- 12.14.5 Amoy Diagnostics Recent Developments
- 12.15 DiaSorin
- 12.15.1 DiaSorin Company Information
- 12.15.2 DiaSorin Business Overview
- 12.15.3 DiaSorin Revenue in Retrovirus Testing Business (2021-2026)
- 12.15.4 DiaSorin Retrovirus Testing Product Portfolio
- 12.15.5 DiaSorin Recent Developments
- 12.16 bioMérieux
- 12.16.1 bioMérieux Company Information
- 12.16.2 bioMérieux Business Overview
- 12.16.3 bioMérieux Revenue in Retrovirus Testing Business (2021-2026)
- 12.16.4 bioMérieux Retrovirus Testing Product Portfolio
- 12.16.5 bioMérieux Recent Developments
- 12.17 BD
- 12.17.1 BD Company Information
- 12.17.2 BD Business Overview
- 12.17.3 BD Revenue in Retrovirus Testing Business (2021-2026)
- 12.17.4 BD Retrovirus Testing Product Portfolio
- 12.17.5 BD Recent Developments
- 12.18 Abbott Diagnostics
- 12.18.1 Abbott Diagnostics Company Information
- 12.18.2 Abbott Diagnostics Business Overview
- 12.18.3 Abbott Diagnostics Revenue in Retrovirus Testing Business (2021-2026)
- 12.18.4 Abbott Diagnostics Retrovirus Testing Product Portfolio
- 12.18.5 Abbott Diagnostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst